ALKEM LABORATORIES History

The Company was incorporated as a private limited company ?Alkem Laboratories Private Limited? on August 8,1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. Pursuant to the Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of the Company was changed to ?Alkem Laboratories Limited? with effect from October 26, 1988. the registered office was originally located at ?Exhibition Road, Patna ? 800 001, Bihar, India?. the Company filed Company Petition No. 356(17)/ ERB/ 2007 before the Company Law Board, Eastern Region Bench at Kolkata for shifting the registered office of the Company from the State of Bihar to the State of Maharashtra, as approved by a special resolution at its extra-ordinary general meeting held on January 29, 2007. The Company Law Board, Eastern Region Bench at Kolkata passed an order dated July 30, 2007 whereby it confirmed the alteration of the situation clause in the Memorandum of Association, from the State of Bihar to the State of Maharashtra. Pursuant to the order, the registered office of the Company was shifted to ?Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai ? 400 013, Maharashtra, India? with effect from August 2, 2007.



Major Events :

1973

-Incorporation of the Company.

1978

-the Company established its first plant at Taloja, Maharashtra.

1988

-the Company became a deemed public limited company.

1992

-the Company established its manufacturing facility in Mandwa, Maharashtra. This facility was converted into an API facility in 2005.

1998

-the Company established its Kachigam manufacturing facility in Gujarat.

2001

-Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company.

2002

-the Company established its Amaliya manufacturing facility in Gujarat.

2003

-the Company set up its research and development facility at Taloja, Maharashtra.

2005

-the Company established its manufacturing facility in Baddi, Himachal Pradesh.

2006

-the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India (Source: IMS Research)

2007

-the Company established its manufacturing facility in Kumrek, Sikkim.

-the Company filed its first ANDA in the United States for the drug, Amlodipine.

-the Company shifted its Registered Office from Patna, Bihar to Mumbai, Maharashtra.

2009

-the Company acquired Pharmacor, a generic pharma company in Australia.

2010

-the Company acquired The PharmaNetwork, LLC, the holding company of Ascend Laboratories LLC.

2011

-the Company acquired Enzene Bio sciences Limited.

2012

-the Company acquired an API manufacturing facility in the United States.

2014

-the Company acquired the Clindac.

2015

-the Company acquired a formulation manufacturing facility in the United States.


Awards and achievements:

2002

-the Company was awarded the Pharma Business and Technology Excellence Award in 2002 as ''India?s Most Esteemed Pharmaceutical Company''

2004

-the product Taxim was awarded the Pharma Business and Technology Excellence Award for successful brand in 2004

2005

-the Company was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005

2009

-the Company received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI

-the Company received the certificate of appreciation in the category of ?Formulation Experts? by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI

2013
-the Company was awarded the India?s most admired pharma company award for 2013 at the 6th Annual Pharmaceutical Leadership Summit in 2013

2014
-the Product ?Clavam? was awarded as the ? Brand of the Year? at the AWACS Award, 2014

2016
-Alkem''s Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA
-Alkem receives EIR from the US FDA for its Daman formulation facility

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.
“2019 © COPYRIGHT DYNAMIC EQUITIES PVT. LTD.”

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at compliance@dynamiclevels.com

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS